Potential tumor markers for human gastric cancer: An elevation of glycan:sulfotransferases and a concomitant loss of α1,2-fucosyltransferase activities

Journal of Cancer Research and Clinical Oncology

Volumn 133, Issue 9, 2007, Pages 599-611

  Chandrasekaran, E V ^a   Xue, Jun ^a   Piskorz, Conrad ^a   Locke, Robert D ^a   Tóth, Károly ^a   Slocum, Harry K ^a   Matta, Khushi L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Carbohydrate; Enzyme activities; Gastric tumor; Glycosyltransferases; Sulfotransferases

Indexed keywords

FUCOSYLTRANSFERASE; GLYCAN; OLIGOSACCHARIDE; SULFOTRANSFERASE; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNET RING CARCINOMA; STOMACH CANCER; STOMACH SARCOMA;

CARCINOMA; FUCOSYLTRANSFERASES; GLYCOSYLTRANSFERASES; HUMANS; POLYSACCHARIDES; STOMACH NEOPLASMS; SULFOTRANSFERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 34447531767     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-007-0206-0     Document Type: Article

References (36)

1. Allen HJ, Ahmed H, Matta KL (1998) Binding of synthetic sulfated ligands by human splenic galectin 1, a β-galactoside-binding lectin. Glycoconj J 15:691-695
2. Amado M, Carneiro F, Seixas M, Clausen H, Sobrinho-Simoes M (1998) Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology 114:462-470
3. Campanero-Rhodes MA, Childs RA, Kiso M, Komba S, Narvor CL, Warren J, Otto D, Crocker PR, Feizi T (2006) Carbohydrate microarrays reveal sulphation as a modulator of siglec binding. Biochem Biophys Res Commun 292:1141-1146
4. Carvalho F, David L, Aubert JP, Lopez-Ferrer A, De Bolos C, Reis CA, Gartner F, Peixoto A, Alves P, Sobrinho-Simoes M (1999) Mucins and mucin-associated carbohydrate antigens expression in gastric carcinoma cell lines. Virchows Arch 435:479-485
5. Chandrasekaran EV, Jain RK, Larsen RD, Wlasichuk K, Matta KL (1995) Selectin-ligands and tumor associated carbohydrate structures: specificities of α2,3-sialyltransferases in the assembly of 3′-sialyl, 6-sulfo/sialyl Lewis a and x, 3′-sialyl, 6′-sulfo Lewis x and 3′-sialyl, 6-sialyl/sulfo blood group T-hapten. Biochemistry 34:2925-2936
6. Chandrasekaran EV, Jain RK, Larsen RD, Wlasichuk K, DiCioccio RA, Matta KL (1996) Specificity analysis of three clonal and five non-clonal α1,3-l-fucosyltransferases with sulfated, sialylated, or fucosylated synthetic carbohydrates as acceptors in relation to the assembly of 3′-sialyl-6′-sulfo Lewis x (the l-selectin ligand) and related complex structures. Biochemistry 35:8925-8933
7. Chandrasekaran EV, Jain RK, Vig R, Matta KL (1997) The enzymatic sulfation of glycoprotein carbohydrate units: blood group T-hapten specific and two other distinct Gal:3-O-sulfotransferases as evident from specificities and kinetics and the influence of sulfate and fucose residues occurring in the carbohydrate chain on C-3 sulfation of terminal Gal. Glycobiology 7:753-768
8. Chandrasekaran EV, Chawda R, Piskorz C, Locke RD, Ta A, Sharad G, Odunsi K, Lele S, Matta KL (2001) Human ovarian cancer, lymphoma spleen, and bovine milk GlcNAc:β1,4Gal/GalNAc transferases: two molecular species in ovarian tumor and induction of GalNAcβ1,4Glc synthesis by α-lactalbumin. Carbohydr Res 334:105-118
9. Chandrasekaran EV, Lakhaman SS, Chawda R, Piskorz CF, Neelamegham S, Matta KL (2004) Identification of physiologically relevant substrates for cloned Gal:3-O-sulfotransferases (Gal3STs): distinct high affinity of Gal3ST-2 and LS180 sulfotransferase for the Globo H backbone, Gal3ST-3 for N-glycan multiterminal Galβ1, 4GlcNAcβ- units and 6-sulfoGalβ1, 4GlcNAcβ-, and Gal3ST-4 for the mucin core-2 trisaccharide. J Biol Chem 279:10032-10041
10. Chandrasekaran EV, Xue J, Xia J, Chawda R, Piskorz C, Locke RD, Neelamegham S, Matta KL (2005) Analysis of the specificity of sialyltransferases toward mucin Core2, Globo, and related structures. Identification of the sialylation sequence and the effects of sulfate, fucose, methyl and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands and novel sialylation by cloned α2,3(O)sialyltransferase. Biochemistry 44:15619-15635
11. Chandrasekaran EV, Xue J, Neelamegham S, Matta KL (2006) The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Carbohydr Res 341:983-994
12. Comelli EM, Head SR, Gilmartin T, Whisenant T, Haslam SM, North SJ, Wong N, Kudo T, Narimatsu H, Esko JD, Drickamer K, Dell A, Paulson JC (2006) A focused microarray approach to functional glycomics: transcriptional regulation of the glycome. Glycobiology 16:117-131
13. Davis DW, McConkey DJ, Zhang W, Herbst RS (2003) Antiangiogenic tumor therapy. BioTechniques 34:1048-1063
14. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
15. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333:32-41
16. Fukuda M (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56:2237-2244
17. Hakomori S (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99:10231-10233
18. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Tsutsumi S, Hirakawa K, Kodama T, Aburatani H (2001) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61:889-895
19. Hiraiwa N, Dohi T, KawakamiKimura N, Yumen M, Ohmori K, Maeda M, Kannagi R (1996) Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha1 → 3 fucosyltransferase (Fuc-T VII). J Biol Chem 271:31556-31561
20. 3- → 3Galβ1 → 3GalNAc pyranoside. Glycobiology 12:199-208
21. Khaldoyanidi SK, Glinsky VV, Sikora L, Glinskii AB, Mossine VV, Quinn TP, Glinsky GV, Sriramarao P (2003) MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galecin-3 interactions. J Biol Chem 278:27-4134
22. Kobayashi T, Honke K, Tsunematsu I, Kagaya H, Nishikawa S, Hokari K, Kato M, Takeda H, Sugiyama T, Higuchi A, Asaka M (1999) Detection of cerebroside sulfotransferase mRNA in human gastric mucosa and adenocarcinoma. Cancer Lett 138:45-51
23. Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ (2001) Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J Cancer Res Clin Oncol 127:375-386
24. Layke JC, Lopez PP (2004) Gastric cancer: diagnosis and treatment options. Am Fam Physician 69:1133-1140
25. Natomi H, Saitoh T, Sugano K, Iwamori M, Fukayama M, Nagai Y (1993) Systemic analysis of glycosphingolipids in the human gastrointestinal tract: enrichment of sulfatides with hydroxylated longer-chain fatty acids in the gastric and duodenal mucosa. Lipids 28:737-742
26. O'Hanlon TP, Lau KM, Wang XC, Lau JT (1989) Tissue-specific expression of beta-galactoside alpha 2,6-sialyltransferase. J Biol Chem 264:17289-17394
27. Palcic MM, Heerze LD, Pierce M, Hindsgaul O (1988) The use of hydrophobic synthetic glycosides as acceptors in glycosyltransferase assays. Glycoconj J 5:49-63
28. Paulson JC, Weinstein J, Schauer A (1989) Tissue-specific expression in of sialyltransferases. J Biol Chem 264:10931-10934
29. Petretti T, Schulze B, Schlag PM, Kemmner W (1999) Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428:209-218
30. Poste G, Fidler IJ (1980) The pathogenesis of cancer metastasis. Nature 283:139-146
31. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54
32. Santos-Silva F, Fonseca A, Caffrey T, Carvalho F, Mesquita P, Reis C, Almeida R, David L, Hollingsworth MA (2005) Thomsen-Friedenreich antigen expression in gastric carcinomas is associated with MUC1 mucin VNTR polymorphism. Glycobiology 15:511-517
33. Sogn JA, Anton-Culver H, Singer DS (2005) Meeting reports: NCI think tanks in cancer biology. Cancer Res 65:9117-9120
34. Taniguchi N, Yoshimura M, Miyoshi E, Ihara Y, Nishikawa A, Fuji S (1996) Remodeling of cell surface glycoproteins by N-acetylglucosaminyltransferase III gene transfection: modulation of metastatic potentials and down regulation of hepatitis B virus replication. Glycobiology 6:691-694
35. Taylor-Papadimitriou J, Burchell J, Miles DW, Dalziel M (1999) MUC1 and cancer. Biochim Biophys Acta 1455:301-313
36. Werther JL, Tatematsu M, Klein R, Kurihara M, Kumagai K, Llorens P, Neto JG, Bodian C, Pertsemlidis D, Yamachika T, Kitou T, Zkowitz S (1996) Sialosyl-Tn antigen as a marker of gastric cancer progression: an international study. Int J Cancer 69:193-199